LONA:NASDAQ
LeonaBio Inc
5,75 $
0,00%
(0,00) 1D
5,73 $
arrow_downward
-0,35% (-0,020)bedtimeAfter hours
Closed: 9 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONA...
Open
5,82 $
High
6,10 $
Low
5,56 $
Mkt. cap
54,17 млн
Avg. vol.
341,74 м.
Volume
66,68 мың
52-wk high
14,19 $
52-wk low
2,21 $
EPS
-19,72 $
Beta
2,11
Shares outstanding
9,42 млн
No. of employees
19
Open
5,82 $
High
6,10 $
Low
5,56 $
Mkt. cap
54,17 млн
Avg. vol.
341,74 м.
Volume
66,68 мың
52-wk high
14,19 $
52-wk low
2,21 $
EPS
-19,72 $
Beta
2,11
Shares outstanding
9,42 млн
No. of employees
19
News stories
From web sources and news partners
Simply Wall Street
·
1 сағат бұрын
What AppLovin Bears Saw Before A 51% Drop
Yahoo Finance
·
5 сағат бұрын
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
24/7 Wall St.
·
19 сағат бұрын
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Seeking Alpha
·
13 сағат бұрын
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Profile
Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.
The company was founded in 2011 and is headquartered in Seattle. Funding that supports the company is from both public and private investment groups including the Alzheimer's Drug Discovery Foundation, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund, The W Fund, WRF Capital, and other private investors.
Leen Kawas served as the company's first President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." In 2025, the company paid a $4 million settlement in relation to allegations that the CEO falsified research to secure a federal grant. On October 21, 2021, Mark Litton, Ph.D., M.B.A. became chief executive officer. Wikipedia
About LeonaBio Inc
CEO-
Employees19
Founded2011
HeadquartersBothell, Вашингтон, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteleonabio.com